Cytoreduction combined with intraperitoneal hyperthermic perfusion chemotherapy in advanced/recurrent ovarian cancer patients: The experience of National Cancer Institute of Milan.

MLA

Raspagliesi, F., et al. “Cytoreduction Combined with Intraperitoneal Hyperthermic Perfusion Chemotherapy in Advanced/Recurrent Ovarian Cancer Patients: The Experience of National Cancer Institute of Milan.” European Journal of Surgical Oncology, vol. 32, no. 6, Aug. 2006, pp. 671–75. EBSCOhost, https://doi.org/10.1016/j.ejso.2006.03.011.

APA

Raspagliesi, F., Kusamura, S., Campos Torres, J. C., de Souza, G. A., Ditto, A., Zanaboni, F., Younan, R., Baratti, D., Mariani, L., Laterza, B., & Deraco, M. (2006). Cytoreduction combined with intraperitoneal hyperthermic perfusion chemotherapy in advanced/recurrent ovarian cancer patients: The experience of National Cancer Institute of Milan. European Journal of Surgical Oncology, 32(6), 671–675. https://doi.org/10.1016/j.ejso.2006.03.011

Chicago

Raspagliesi, F., S. Kusamura, J.C. Campos Torres, G.A. de Souza, A. Ditto, F. Zanaboni, R. Younan, et al. 2006. “Cytoreduction Combined with Intraperitoneal Hyperthermic Perfusion Chemotherapy in Advanced/Recurrent Ovarian Cancer Patients: The Experience of National Cancer Institute of Milan.” European Journal of Surgical Oncology 32 (6): 671–75. doi:10.1016/j.ejso.2006.03.011.